Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodi Strong

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetes Spectrum : a Publication of the American Diabetes Association|May 19, 2018
iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 DiabetesDebbie Hinnen, Jodi Strong
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 29, 2019
The Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic BenefitDhiren K Patel, Jodi Strong
Diabetes Spectrum : a Publication of the American Diabetes Association|June 7, 2019
Insulin Initiation and Titration in Patients With Type 2 DiabetesJi Chun, Jodi Strong, Scott Urquhart
Current Medical Research and Opinion|January 31, 2017
Insulin glargine 300 units/mL: a guide for healthcare professionals involved in the management of diabetesJodi Strong, Davida Kruger, Lucia Novak
The Journal of Family Practice|March 22, 2023
Evolution and Revolution-Our Changing Relationship With InsulinJohn Anderson, Mary Van Doorn, Jodi Strong
Clinical Diabetes : a Publication of the American Diabetes Association|November 2, 2020
How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?Joseph Tibaldi, Max E Mercado, Jodi Strong
The Journal of Family Practice|June 21, 2019
Real-world evidence in diabetes: relevance to clinical practiceLawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 16, 2018
Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support ProgramJennifer D Goldman, Jasvinder Gill, Tony Horn, et al.
Diabetes, Obesity & Metabolism|June 16, 2020
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trialLuigi Meneghini, Lawrence Blonde, Jasvinder Gill, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|December 6, 2021
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life StudyTimothy S Bailey, Pierre Evenou, Jasvinder Gill, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetes Spectrum : a Publication of the American Diabetes Association|May 19, 2018
iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 DiabetesDebbie Hinnen, Jodi Strong
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 29, 2019
The Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic BenefitDhiren K Patel, Jodi Strong
Diabetes Spectrum : a Publication of the American Diabetes Association|June 7, 2019
Insulin Initiation and Titration in Patients With Type 2 DiabetesJi Chun, Jodi Strong, Scott Urquhart
Current Medical Research and Opinion|January 31, 2017
Insulin glargine 300 units/mL: a guide for healthcare professionals involved in the management of diabetesJodi Strong, Davida Kruger, Lucia Novak
The Journal of Family Practice|March 22, 2023
Evolution and Revolution-Our Changing Relationship With InsulinJohn Anderson, Mary Van Doorn, Jodi Strong
Clinical Diabetes : a Publication of the American Diabetes Association|November 2, 2020
How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?Joseph Tibaldi, Max E Mercado, Jodi Strong
The Journal of Family Practice|June 21, 2019
Real-world evidence in diabetes: relevance to clinical practiceLawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 16, 2018
Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support ProgramJennifer D Goldman, Jasvinder Gill, Tony Horn, et al.
Diabetes, Obesity & Metabolism|June 16, 2020
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trialLuigi Meneghini, Lawrence Blonde, Jasvinder Gill, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|December 6, 2021
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life StudyTimothy S Bailey, Pierre Evenou, Jasvinder Gill, et al.
Pageof 2